October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible ...
July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system ...
By Dave Fornell, DAIC editor
The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) ...
November 8, 2013 – According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) ...
Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top ...
July 15, 2013 — Shore University Medical Center is one of only a handful of hospitals in the country offering the recent ...
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented ...
June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has ...
May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrat ...
May 2, 2013 — Simbionix USA Corp. released various training modules for the Angio Mentor endovascular simulator.
The ...